JPH03294209A - Collagen treatment material for dental and oral surgery - Google Patents
Collagen treatment material for dental and oral surgeryInfo
- Publication number
- JPH03294209A JPH03294209A JP2094970A JP9497090A JPH03294209A JP H03294209 A JPH03294209 A JP H03294209A JP 2094970 A JP2094970 A JP 2094970A JP 9497090 A JP9497090 A JP 9497090A JP H03294209 A JPH03294209 A JP H03294209A
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- dental
- crosslinking
- oral surgery
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、歯科及び口腔外科領域における歯周病治療、
歯肉上皮の歯根尖側方向への成長すなわちダウングロー
スの防止や抜歯窩填塞治療などに用いる治療用コラーゲ
ン組成物に関する。Detailed Description of the Invention (Industrial Field of Application) The present invention relates to periodontal disease treatment in the field of dentistry and oral surgery;
The present invention relates to a therapeutic collagen composition used to prevent the growth of gingival epithelium in the apical direction of teeth, that is, downgrowth, and to fill tooth extraction sockets.
(従来の技術及び解決しようとする課題)歯周治療の最
終的な目的は歯周炎等で破壊された歯周組織の再生にあ
る。通常の外科的処理のみ行なった場合にはその治癒形
態はセメント質や歯根膜を生成する細胞が上皮より先に
特異に歯根表面に到達することはなく、最初に」1皮が
結合組織に沿って歯根表面に埋入してしまい結果的には
長い接合上皮を形成する。セメント質や歯根膜の存在し
ない二の線維性の付着は弱々しいもので、歯牙の咬合機
能を完全には回復しない。更にはこの歯根上皮と歯根と
の直接な付着は歯根の吸収を招く。(Prior Art and Problems to Be Solved) The ultimate purpose of periodontal treatment is to regenerate periodontal tissue destroyed by periodontitis or the like. When only normal surgical treatment is performed, the healing process is such that the cells that produce cementum and periodontal ligament do not specifically reach the tooth root surface before the epithelium; and become embedded in the tooth root surface, resulting in the formation of a long junctional epithelium. The second fibrous attachment, which lacks cementum and periodontal ligament, is weak and does not completely restore the tooth's occlusal function. Furthermore, this direct attachment of the tooth root epithelium to the tooth root leads to resorption of the tooth root.
そこで歯根を他の組織から隔離して、セメント質や歯根
膜を生成する細胞を選択的に歯根表面に集合させるとい
う考えの基に歯根と歯肉との間に各種の膜を挿入すると
いう試みがなされてきた。Therefore, attempts have been made to insert various membranes between the tooth root and the gingiva, based on the idea of isolating the tooth root from other tissues and selectively assembling cells that produce cementum and periodontal ligament on the tooth root surface. It has been done.
例えばMllllpOer FalterやGore−
Tex membraneを使った場合、確かにセメン
ト質や歯根膜は歯根の周りに再生されるが膜自体は生体
内非吸収性のため歯肉結合組織及び上皮を再生するため
には膜移植後ある時期に再度膜摘出のための外科手術を
行なわねばならず操作が煩雑であり、あまり実用的でな
かった。またコラーゲン膜の例ではアテロコラーゲンの
シートを用いた報告がある(鴨井久−他、東京都歯科医
師会雑誌:第36巻第4号・1988年4月几りラーゲ
ンは生体内分解性であるため、摘出のための再手術が必
要でなく、また歯根の周りにセメント質、歯根膜が存在
しそこに結合組織が付着するという理想的な治癒形態を
示した。しかし時として、セメント質、歯根膜が再生さ
れる以前に生体内で分解されたり、分解されないまでも
体液による膨張のため膜の形態を保たなくなる場合があ
った。また膜自体の強度不足のためその押入に際しては
熟練した技量と細心の注意を要し、その取扱は困難であ
った。For example, MllllpOer Falter and Gore-
When using a Tex membrane, it is true that cementum and periodontal ligament are regenerated around the tooth root, but since the membrane itself is non-absorbable in the body, it is necessary to regenerate the gingival connective tissue and epithelium at some point after membrane transplantation. The surgical procedure for removing the membrane had to be performed again, making the operation complicated and not very practical. In addition, as an example of a collagen membrane, there is a report using a sheet of atelocollagen (Hisashi Kamoi et al., Journal of the Tokyo Dental Association: Vol. 36, No. 4, April 1988). This study demonstrated an ideal form of healing in which reoperation for extraction was not necessary, and cementum and periodontal ligament existed around the tooth root, to which connective tissue was attached. In some cases, the membrane decomposes in the body before it can be regenerated, or even if it is not decomposed, the membrane loses its shape due to expansion by body fluids.Furthermore, the membrane itself is insufficiently strong, so it takes a lot of skill to push it in. It required extreme care and was difficult to handle.
ところで、コラーゲンは、動物の結合組織を構成する主
要なタンパク質であり、その構造は動物種を問わずほぼ
同じ構造をもつ。そのため異種動物由来のコラーゲンで
あっても、他のタンパク質とは異なり抗原性は極めて低
く、組織適合性に優れるという特徴を有する。通常組織
を構成するコラーゲンはその分子間に架橋を有し組織と
しての形態を保っている。アテロコラーゲンとは、酵素
などで処理することによりこの分子間架橋を切断し、更
には抗原発現部位であるテロベプタイドを除去したもの
である。By the way, collagen is a major protein that constitutes the connective tissue of animals, and its structure is almost the same regardless of animal species. Therefore, unlike other proteins, even collagen derived from a different species of animal has extremely low antigenicity and excellent tissue compatibility. Collagen, which normally constitutes tissue, has crosslinks between its molecules and maintains its tissue form. Atelocollagen is produced by treating with an enzyme or the like to cleave the intermolecular crosslinks and further remove telopeptide, which is the antigen expression site.
以上示したようにコラーゲン、特にアテロコラーゲンは
極めて組織適合性に優れたものであるが、そのままでは
生体内での分解吸収が速く治療目的を十分に果たす前に
分解吸収されてしまうという欠点があった。この生体内
での分解吸収速度を制御すべく種々の方法で架橋を導入
することが行なわれている。しかし架橋の導入により生
体内分解吸収性の制御は出来ても、その組成物の強度を
目的とするところまで十分に向上させることは出来なか
った。As shown above, collagen, especially atelocollagen, has extremely excellent tissue compatibility, but it has the disadvantage that it is rapidly degraded and absorbed in the living body and is degraded and absorbed before it can fully fulfill its therapeutic purpose. . In order to control the rate of decomposition and absorption in vivo, various methods have been used to introduce crosslinks. However, although it was possible to control biodegradability and absorption by introducing crosslinking, it was not possible to sufficiently improve the strength of the composition to the desired level.
本発明は、コラーゲンにより構成されるスポンジ及びシ
ート状の構造で、充分な強度を有し、且つ生体内におけ
る分解吸収性を制御した、歯科及び口腔外科領域におけ
る治療用コラーゲン組成物を供することを目的とする。The present invention aims to provide a collagen composition for treatment in the field of dentistry and oral surgery, which has a sponge or sheet-like structure composed of collagen, has sufficient strength, and has controlled decomposition and absorption in vivo. purpose.
(課題を解決するための手段)
本発明者は、コラーゲン膜に関して強度及び生体吸収速
度を種々検討した結果、可溶性コラーゲンに線維性コラ
ーゲンを適当な割合で配合し、架橋剤により架橋処理す
ることにより、その強度並びに生体吸収速度が極めて向
上することを見出し、本発明を完成した。(Means for Solving the Problems) As a result of various studies on the strength and bioabsorption rate of collagen membranes, the present inventor found that by blending fibrous collagen into soluble collagen in an appropriate ratio and crosslinking it with a crosslinking agent. The present invention was completed based on the discovery that the strength and rate of bioabsorption are significantly improved.
すなわち、本発明は、可溶性コラーゲン95〜40重量
2と線維性コラーゲン5〜60重量%とからなるコラー
ゲン組成物を架橋化した歯科及び口腔外科用コラーゲン
治療材である。That is, the present invention is a collagen treatment material for dentistry and oral surgery in which a collagen composition comprising 95 to 40% by weight of soluble collagen and 5 to 60% by weight of fibrous collagen is crosslinked.
本発明で用いる可溶性コラーゲンとは、ウシ、ラット、
マウス等の哺乳動物、更には鳥類、魚類等の種々の動物
から酸により抽出したコラーゲン、或いはこれら動物の
結合組織から酵素を用いて溶解、抽呂したアテロコラー
ゲン又はアルカリ処理により抽出したコラーゲン、更に
はこれらを化学修飾したコラーゲン誘導体の如き、水に
溶解して均一な水溶液を形成し得るものである。特に牛
の真皮をペプシンを用い可溶化したアテロコラーゲンが
望ましい。The soluble collagen used in the present invention includes bovine, rat,
Collagen extracted with acid from mammals such as mice, as well as various animals such as birds and fish, or atelocollagen dissolved and extracted using enzymes from the connective tissues of these animals, or collagen extracted by alkali treatment. These are chemically modified collagen derivatives that can be dissolved in water to form a uniform aqueous solution. Particularly desirable is atelocollagen made from bovine dermis solubilized using pepsin.
また、本発明で用いる線維性コラーゲンとしては、鍵よ
り単離した鍵由来コラーゲン、或いは獣皮の真皮層から
得られる架橋されたコラーゲン等を用いることができる
。特に腱由来のコラーゲンを用いることが望ましい。鍵
由来のコラーゲンは線維が長く、可溶性コラーゲンと混
合して用いた場合、その成形物の力学的特性を大いに改
善することができる。Further, as the fibrous collagen used in the present invention, key-derived collagen isolated from keys, crosslinked collagen obtained from the dermal layer of animal skin, etc. can be used. In particular, it is desirable to use collagen derived from tendons. Collagen derived from keys has long fibers, and when used in combination with soluble collagen, the mechanical properties of molded products can be greatly improved.
更に、鍵は他の臓器に比較してコラーゲン以外のタンパ
ク質が少なく精製が容易である。鍵由来コラーゲンの精
製は有機溶剤を用い脂肪などを溶解分離した後、タンパ
ク変性剤を用いてコラーゲンが変性し難く、他のタンパ
ク質が変性溶出する条件にて洗浄することにより精製可
能であることを見出した。これにより、線維性コラーゲ
ンを生態に安全に適用することが可能となった。Furthermore, the key is that compared to other organs, there are fewer proteins other than collagen and it is easy to purify. It has been shown that key-derived collagen can be purified by dissolving and separating fat using an organic solvent, and then washing with a protein denaturing agent under conditions that prevent collagen from being denatured and that allow other proteins to denature and elute. I found it. This has made it possible to safely apply fibrillar collagen ecologically.
前述したように可溶性コラーゲンと線維性コラーゲンよ
りなるコラーゲン組成物は、目的とする強度、柔軟性な
どの力学的特性、及び生体内分解吸収速度などにより任
意の割合にて混合し用いることが出来るが、可溶性コラ
ーゲン95〜40重量tと線維性コラーゲン5〜60重
量%が望ましく、特に、望ましい混合比は、可溶性コラ
ーゲン90〜70重量%と線維性コラーゲンlO〜30
量2である。As mentioned above, a collagen composition consisting of soluble collagen and fibrous collagen can be mixed and used in any proportion depending on the desired mechanical properties such as strength and flexibility, as well as the rate of biodegradation and absorption. , 95-40% by weight of soluble collagen and 5-60% by weight of fibrous collagen are desirable. In particular, a desirable mixing ratio is 90-70% by weight of soluble collagen and 10-30% by weight of fibrous collagen.
The amount is 2.
この混合操作は、可溶性コラーゲンの5%以下の濃度の
酸性水溶液に、線維性コラーゲンの2z以下の濃度の酸
性サスペンションを加え分散させることにより行なう。This mixing operation is carried out by adding and dispersing an acidic suspension of fibrous collagen at a concentration of 2z or less to an acidic aqueous solution of soluble collagen at a concentration of 5% or less.
この際、全コラーゲンの濃度は3%以下が望ましい。こ
の操作は、溶液温度が20℃以上にならないように温度
上昇に注意しながらホモジナイザーなどにより撹拌して
行なう。この均一な酸性分散液はそのまま、或いは中和
して凍結乾燥又は風乾してスポンジまたはシート状に成
型する。その後プレスして、膨潤時の厚さが500μm
以下になるようにする。At this time, the concentration of total collagen is preferably 3% or less. This operation is performed by stirring with a homogenizer or the like while paying attention to temperature rise so that the solution temperature does not exceed 20°C. This homogeneous acidic dispersion may be molded into a sponge or sheet by being lyophilized or freeze-dried or air-dried as it is or after neutralization. After that, it is pressed to a thickness of 500 μm when swollen.
Make it as follows.
未架橋のコラーゲン膜をそのまま生体に適応した場合、
体液などにより膨潤してしまい取扱が困難になったり、
また移植後1週間程で分解吸収されてしまう。そのため
にコラーゲンスポンジは架橋処理する。架橋剤としては
従来良く知られているもの、例えばホルムアルデヒド、
ゲルタールアルデヒド等のアルデヒド化合物、ヘキサメ
チレンジイソシアネート等のイソシアネート化合物、あ
るいはポリエポキシ化合物を用いることができる。When an uncrosslinked collagen membrane is directly applied to a living body,
It may become difficult to handle due to swelling due to body fluids, etc.
In addition, it will be degraded and absorbed about a week after transplantation. For this purpose, collagen sponges are cross-linked. Conventionally well-known crosslinking agents include formaldehyde,
Aldehyde compounds such as geltaraldehyde, isocyanate compounds such as hexamethylene diisocyanate, or polyepoxy compounds can be used.
特に細胞毒性など刺激の無いヘキサメチレンジイソアネ
ートが好ましい。また架橋の度合は、移植後3週間以上
膜の形状を保っていることが望ましい。Particularly preferred is hexamethylene diisoanate, which does not cause irritation such as cytotoxicity. The degree of crosslinking is such that it is desirable that the membrane maintains its shape for three weeks or more after transplantation.
実施例
(1)アテロコラーゲンの調製
新鮮な仔牛の皮を精製水で充分に洗浄し付着している汚
れを取り除いた。70%エチルアルコールで消毒後、除
毛して剃刀で毛根部を残さないように皮の表面を削ぎ落
とし、更に裏面も同様に操作し脂肪層等を取り除き真皮
層を得た。これを細断し、5%NaC1水で洗浄後、真
皮100 gに対して4Qの蒸留水を加えて、IN H
cIでpH3,0に調整し、ペプシン0.2gを加え間
欠的な撹拌を行ないながら5日問20℃に保った。Example (1) Preparation of atelocollagen Fresh calf skin was thoroughly washed with purified water to remove adhering dirt. After disinfection with 70% ethyl alcohol, the hair was removed and the surface of the skin was scraped off with a razor so as not to leave any hair roots.Furthermore, the same operation was performed on the back side to remove the fat layer and the like to obtain the dermal layer. This was shredded and washed with 5% NaCl water, then 4Q distilled water was added to 100 g of dermis, and IN H
The pH was adjusted to 3.0 with cI, 0.2 g of pepsin was added, and the mixture was kept at 20° C. for 5 days with intermittent stirring.
この処理によって得られた可溶性コラーゲン水溶液をペ
プシンを不活化するためにそのpHを10に調整しくN
a0H)24時間4℃に保った。The pH of the soluble collagen aqueous solution obtained by this treatment was adjusted to 10 to inactivate pepsin.
a0H) It was kept at 4°C for 24 hours.
その後、等電点沈澱法及び濾過を繰り返すことによヲ7
゛コラーゲンを精製し、無菌で発熱性物質の無いアテロ
コラーゲンを得た。After that, by repeating the isoelectric precipitation method and filtration,
``Collagen was purified to obtain sterile and pyrogen-free atelocollagen.
(2)N!l由来コラーゲンの調製
新鮮な牛のアキレス鍵のシース(鞘)をハサミで取り除
いた。シースのないY字型の鍵をミートスライサーによ
り1〜2薗厚にスライスした。均一に且つ個々の線維に
分離するためにMicro−Cutで2〜3回処理した
。この操作により線維長は0.2mm以下になった。微
細になった鍵のコラーゲン線維は、脂肪成分を除去する
ため例えばエチルアルコール−エチルエーテルのような
脂肪溶剤で2度洗浄し、遠心分離により回収した。さら
に他のタンパク質等の不純物を除去するため、コラーゲ
ンに対し30倍量の1M塩化カルシウム水溶液を用い4
℃で洗浄した。この操作によりコラーゲン中の、例えば
アルブミンの含有量は1 ppm以下であった。(2) No! Preparation of Collagen from L. The sheath of a fresh bovine Achilles key was removed with scissors. A Y-shaped key without a sheath was sliced into 1 to 2 thick slices using a meat slicer. It was treated with Micro-Cut 2-3 times to separate it uniformly and into individual fibers. This operation reduced the fiber length to 0.2 mm or less. The finely divided key collagen fibers were washed twice with a fat solvent such as ethyl alcohol-ethyl ether to remove fat components, and recovered by centrifugation. Furthermore, in order to remove impurities such as other proteins, a 1M calcium chloride aqueous solution was used, which was 30 times the amount of collagen.
Washed at °C. By this operation, the content of albumin, for example, in collagen was 1 ppm or less.
その後戻に蒸留水での洗浄、回収を繰り返し、生体適応
可能な腱由来線維性コラーゲンを得た。Thereafter, washing with distilled water and recovery were repeated to obtain biocompatible tendon-derived fibrous collagen.
(3)コラーゲンスポンジの製造
前記(1)で調製したアテロコラーゲンを用い2重量%
の酸性水溶液(pH3;HCI)を作製した。また、前
記(2)で調製した鍵出来コラーゲンを用い、コラーゲ
ン濃度が2重量%の酸性分散液 (pH3;HCI)を
作製した。このアテロコラーゲン水溶液と腱由来コラー
ゲン分散液とを、重量比で、(a)too:O。(3) Production of collagen sponge Using atelocollagen prepared in (1) above, 2% by weight
An acidic aqueous solution (pH 3; HCI) was prepared. Furthermore, an acidic dispersion (pH 3; HCI) having a collagen concentration of 2% by weight was prepared using the Kagideki collagen prepared in (2) above. The weight ratio of this atelocollagen aqueous solution and tendon-derived collagen dispersion was (a) too:O.
(b)90: 10. (c)60:40. (d)4
0:60の割合で混合した。(b) 90: 10. (c) 60:40. (d)4
They were mixed at a ratio of 0:60.
その後ホモジナイザーで撹拌しなからNaOHで中和し
、pH7〜8の分散液を得た。この分散液をIM厚に凍
結乾燥用トレーに分注し、凍結乾燥を行なった。得られ
たスポンジを0.2mm厚に圧縮した。その後、コラー
ゲンのε−Nl(tに対して5倍モル当量のヘキサメチ
レンジイソシアナートをメチルアルコール中に0.05
%になるように溶がした溶液に、浸漬し振とうしながら
架橋反応を行なった。その後メチルアルコール洗浄及び
水洗浄を行ない、乾燥することにより前記(a)〜(d
)の組成のコラーゲンスポンジシートを得た。このよう
にして得らたコラーゲンスポンジシートのε−NH1の
架橋率は約55〜60%であった。Thereafter, the mixture was stirred with a homogenizer and then neutralized with NaOH to obtain a dispersion having a pH of 7 to 8. This dispersion liquid was dispensed into IM-thickness trays for freeze-drying, and freeze-dried. The obtained sponge was compressed to a thickness of 0.2 mm. Thereafter, 0.05 molar equivalent of hexamethylene diisocyanate was added to methyl alcohol in a 5-fold molar equivalent to ε-Nl (t) of collagen.
The crosslinking reaction was carried out by immersing the sample in a solution containing 100% of the solution and shaking it. After that, the above (a) to (d) are washed with methyl alcohol and water, and dried.
) A collagen sponge sheet with the composition was obtained. The crosslinking rate of ε-NH1 in the collagen sponge sheet thus obtained was about 55 to 60%.
(4)コラーゲンスポンジシートの物性値比較上記(3
)で作製した(a)〜(d)の各組成のコラ−ノンスポ
ンジシートについて、その引っ張り強度1柔軟性を測定
した。引っ張り強度は、各スボン:シートをlc171
X7cmの大きさに切断して、引っ張試験機で測定した
。また柔軟性は、見た目及び=ざわりで評価し、(a)
のコラーゲンスポンジシートを100とし、これを基準
にした。その結果は、表1のとおりであった。(4) Comparison of physical properties of collagen sponge sheets (3)
The tensile strength and flexibility of the cola-non sponge sheets of each composition (a) to (d) prepared in (a) to (d) were measured. The tensile strength of each trousers: sheet is LC171.
It was cut to a size of 7cm x 7cm and measured using a tensile tester. Flexibility was evaluated based on appearance and texture; (a)
The collagen sponge sheet was set as 100, and this was used as a reference. The results were as shown in Table 1.
(5)生体内吸収性
Wister系雌ラット(7退会200〜250g)を
麻酔下で背部を刺毛し、イソジンで消毒後圧中線に対し
て対称に2個ずつ計4カ所約1.5cm角の切開を加え
皮下ポケットを作成した。1CsrI角に切断した前記
(a)〜(d)の各コラーゲンスポンジシート(組成物
)を留置し縫合した。この場合皮膚切開線が埋込材料上
に位置しないよう留意した。1週、2週、3週、4週、
5週、6週及び7週後に解剖し、皮下組織ごと試料を取
りだしホルマリン固定及びパラフィン包埋し組織切片を
作成し、組織学的に評価した。なお、比較のため(b)
の架橋処理しないもの(e)についても評価した。その
結果は、表2のとおりであった。(5) Bioabsorbable Wister female rats (200-250 g) were pierced under anesthesia on the back, and after disinfection with isodine, 2 symmetrical hairs were placed on the midline of pressure at 4 locations, approximately 1.5 cm in total. An incision was made at the corner and a subcutaneous pocket was created. The collagen sponge sheets (compositions) of (a) to (d) cut into 1CsrI angles were placed and sutured. In this case, care was taken to ensure that the skin incision line was not located on the implant material. 1 week, 2 weeks, 3 weeks, 4 weeks,
After 5, 6, and 7 weeks, the mice were dissected, and samples including the subcutaneous tissues were taken out, fixed in formalin, embedded in paraffin, and tissue sections were prepared for histological evaluation. For comparison, (b)
The sample (e) which was not subjected to crosslinking treatment was also evaluated. The results were as shown in Table 2.
(以下余白)
(発明の効果)
本発明のコラーゲン治療材は、可溶性コラーゲンと線維
性コラーゲンとを特定な割合で配合し、架橋化したもの
であるので、強度及び生体吸収速度が改善されたコラー
ゲンシート又はスポンジの形態にすることができ、例え
ば、歯周治療における創傷治癒の促進、歯肉上皮の下方
成長すなわちダウングロースの防止、抜歯窩の填塞後に
おける充填剤の漏出防止など歯科及び口腔外科用コラー
ゲン治療材として極めて有用である。(Margin below) (Effects of the invention) The collagen therapeutic material of the present invention is a crosslinked product containing soluble collagen and fibrous collagen in a specific ratio, so it is a collagen with improved strength and bioabsorption rate. It can be in the form of a sheet or sponge, and is used for dental and oral surgery, such as promoting wound healing in periodontal treatment, preventing the downward growth of the gingival epithelium, and preventing leakage of filling material after filling a tooth extraction socket. It is extremely useful as a collagen treatment material.
Claims (1)
ゲン5〜60重量%とからなるコラーゲン組成物を架橋
化した歯科及び口腔外科用コラーゲン治療材。 2、可溶性コラーゲンがアテロコラーゲンであり、線維
性コラーゲンが腱由来のコラーゲンである請求項1記載
の歯科及び口腔外科用コラーゲン治療材。 3、架橋化が架橋剤ヘキサメチレンジイソシアナートに
より行なわれたものである請求項1又は2記載の歯科及
び口腔外科用コラーゲン治療材。[Scope of Claims] 1. A collagen treatment material for dentistry and oral surgery, which is obtained by crosslinking a collagen composition consisting of 95 to 40% by weight of soluble collagen and 5 to 60% by weight of fibrous collagen. 2. The collagen treatment material for dental and oral surgery according to claim 1, wherein the soluble collagen is atelocollagen and the fibrous collagen is collagen derived from tendon. 3. The collagen therapeutic material for dental and oral surgery according to claim 1 or 2, wherein the crosslinking is carried out using a crosslinking agent hexamethylene diisocyanate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2094970A JPH0818998B2 (en) | 1990-04-12 | 1990-04-12 | Collagen therapeutic material for dental and oral surgery |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2094970A JPH0818998B2 (en) | 1990-04-12 | 1990-04-12 | Collagen therapeutic material for dental and oral surgery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03294209A true JPH03294209A (en) | 1991-12-25 |
| JPH0818998B2 JPH0818998B2 (en) | 1996-02-28 |
Family
ID=14124777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2094970A Expired - Lifetime JPH0818998B2 (en) | 1990-04-12 | 1990-04-12 | Collagen therapeutic material for dental and oral surgery |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0818998B2 (en) |
-
1990
- 1990-04-12 JP JP2094970A patent/JPH0818998B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0818998B2 (en) | 1996-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0132979B1 (en) | Aqueous atelocollagen solution and method of preparing same | |
| Patino et al. | Collagen as an implantable material in medicine and dentistry | |
| KR100381741B1 (en) | Collagen product containing collagen of marine origin with a low odor and with improved mechanical properties, and its use in the form of cosmetic or pharmaceutical compositions or products | |
| CA1261760A (en) | Implant tissue | |
| CA2435159C (en) | A method of preparing a collagen sponge | |
| US5206028A (en) | Dense collagen membrane matrices for medical uses | |
| US20020153632A1 (en) | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge | |
| TWI316943B (en) | Method for producing collagen from mammalian animal skin | |
| US10004825B2 (en) | Collagen materials and methods for obtaining same | |
| US4271070A (en) | Chemically-modified fiber collagen hemostatic agents | |
| EP3055000B1 (en) | Collagen sponge | |
| JPH0430867B2 (en) | ||
| AU2002249528A1 (en) | A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge | |
| JP4662948B2 (en) | Wound care products containing keratin | |
| Hyder et al. | Freeze‐dried, cross‐linked bovine type I collagen: Analysis of properties | |
| KR102330140B1 (en) | Dried implant composition and injectable aqueous implant formulation | |
| CN105709259A (en) | Colloidal collagen gel produced from jellyfish | |
| US5138030A (en) | Process for extracting type I collagen form an avian source, and applications therefor | |
| WO1998044809A1 (en) | Improved process for the manufacture of collagen | |
| JPH0712375B2 (en) | Transplant composition and method for producing the same | |
| RU2353397C2 (en) | Bioabsorbable collagen matrix, method of production and application | |
| JPH0818998B2 (en) | Collagen therapeutic material for dental and oral surgery | |
| RU2433828C1 (en) | Injection heterogenic biopolymer hydrogel for substitutional and regenerative surgery and method of its obtaining | |
| JPH02156954A (en) | Manufacture of collagen film which possesses biological function and using method thereof | |
| JPH05208042A (en) | Adhesive agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100228 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100228 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110228 Year of fee payment: 15 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110228 Year of fee payment: 15 |